| Literature DB >> 28453717 |
Meera Shekar1, Jakub Kakietek1, Mary R D'Alimonte2, Hilary E Rogers2, Julia Dayton Eberwein1, Jon Kweku Akuoku1, Audrey Pereira1, Shan Soe-Lin2, Robert Hecht2.
Abstract
Childhood stunting, being short for one's age, has life-long consequences for health, human capital and economic growth. Being stunted in early childhood is associated with slower cognitive development, reduced schooling attainment and adult incomes decreased by 5-53%. The World Health Assembly has endorsed global nutrition targets including one to reduce the number of stunted children under five by 40% by 2025. The target has been included in the Sustainable Development Goals (SDG target 2.2). This paper estimates the cost of achieving this target and develops scenarios for generating the necessary financing. We focus on a key intervention package for stunting (KIPS) with strong evidence of effectiveness. Annual scale-up costs for the period of 2016-25 were estimated for a sample of 37 high burden countries and extrapolated to all low and middle income countries. The Lives Saved Tool was used to model the impact of the scale-up on stunting prevalence. We analysed data on KIPS budget allocations and expenditure by governments, donors and households to derive a global baseline financing estimate. We modelled two financing scenarios, a 'business as usual', which extends the current trends in domestic and international financing for nutrition through 2025, and another that proposes increases in financing from all sources under a set of burden-sharing rules. The 10-year financial need to scale up KIPS is US$49.5 billion. Under 'business as usual', this financial need is not met and the global stunting target is not reached. To reach the target, current financing will have to increase from US$2.6 billion to US$7.4 billion a year on average. Reaching the stunting target is feasible but will require large coordinated investments in KIPS and a supportive enabling environment. The example of HIV scale-up over 2001-11 is instructive in identifying the factors that could drive such a global response to childhood stunting.Entities:
Keywords: Child health; cost; health financing; malnutrition
Mesh:
Year: 2017 PMID: 28453717 PMCID: PMC5406759 DOI: 10.1093/heapol/czw184
Source DB: PubMed Journal: Health Policy Plan ISSN: 0268-1080 Impact factor: 3.344
Figure 1.Simplified conceptual model of the causes of stunting
Target population, description and summary of the evidence of effectiveness of the interventions included in the analyses
| Intervention | Target population | Description | Evidence of effectiveness |
|---|---|---|---|
| Vitamin A supplementation | Children 6–59 months | Distribution of two doses per year (100 000 international units [IU] for children 6–11months old and 200 000 IU for children 12–59 months old) either through mass campaigns or in health facilities | Vitamin A indirectly affects stunting through influencing diarrhoeal incidence and mortality. Vitamin A supplementation has been shown to reduce diarrhoea-specific incidence [RR 0·85, 95% CI 0·82–0·87; 13 studies] and mortality [RR 0·72, 95% CI 0·57–0·91; 7 studies].a |
| Breastfeeding & complementary feeding counselling | Mothers of children 0–23 months | Individual counselling sessions to promote exclusive breastfeeding & timely introduction of complementary foods | Education on complementary feeding alone improved height-for-age Z scores [SMD 0·23, 95% CI 0·09–0·36; 5 studies], and decreased stunting risk [RR 0·71, 95%CI: 0·60–0·76; 6 studies]. However, there was no significant impact on height gain [SMD 0·23, 95% CI –0·00, 0·45; 6 studies].b |
| Public provision of complementary foods | Children 6–23 months living under the poverty line ($1·25/day) | Food supplementation for children (100–1500 kcal per day), typically including micronutrients | The provision of complementary foods, with or without education increased height-for-age Z score [SMD 0·39, 95% CI 0·05–0·73; 7 studies].c |
| Prophylactic zinc for children | Children 6–-59 months | Zinc (10 mg/day); 120 packets per child per year; Currently, no delivery platforms exist at scale. Cost estimates are based on multiple micronutrient powder supplementation programs | Supplementation with 10 mg zinc/day for 24 weeks increased mean gain in height (cm) [0·37, 95% CI 0·12–0·62; 16 studies] compared to a placebo intervention.d Zinc supplementation also reduced diarrhoeal incidence [RR 0·87, 95% CI 0·81–0·94] in the intervention group compared to a control group.e |
| Multiple micronutrient supplementation for pregnant women | Pregnant women | Broadly defined as a micronutrient supplementation that contains iron and at least two or more micronutrients. The cost was calculated for supplementation containing 15 micronutrients/vitamins including iron and folic acid, for 180 days per pregnancy | When compared to placebos or supplements with fewer than two micronutrients, the UNICEF UNIMAP supplement which contains 14 micronutrients, including iron and folic acid, showed significant effects on low birthweight [RR 0·88, 95% CI 0·85–0·91], small-for-gestational age [RR 0·89, 95% CI 0·83–0·96] and preterm birth [RR 0·97, 95% CI 0·94–0·99].f |
| Balanced energy-protein supplementation | Pregnant women living under the poverty line ($1·25/day) | Food supplementation during pregnancy (with no more than 25% energy content contributed by proteins) | Indirect impact on stunting through reduced risk of low-birth weight infants and infants born small-for-gestational age. When compared with the control group, BEPS resulted in a positive impact in birthweight [mean difference (MD) 73 g, 95% CI 30–117], with effects more clearly pronounced in undernourished women (12 studies) than women with adequate nutrition (7 studies). BEPS also reduced the risk of small-for-gestational age babies [RR 0·66, 95% CI 0·49–0·89; 9 studies], stillbirths [RR 0·62, 95% CI 0·40–0·98; 4 studies] and increased birth length (cm) [MD 0·16, 95% CI 0·02–0·16; 7 studies].h |
| Intermittent preventive treatment in pregnancy | Pregnant women (in malaria endemic areas only) | Two doses of sulfadoxine-pyrimethamine (SP) during pregnancy | Among first and second births, supplementation with IPTp-SP led to higher birthweight [Weighted MD 126·70, 95% CI 88·64–164·75; 8 trials; 2648 participants] compared to those with placebo or no intervention. The intervention also decreased risk of low birthweight [RR 0·57, 95% CI 0·46–0·72; 6 trials; 2350 participants], increased mean birth weight [MD 92·72, CI 95% CI 62·05–123·39; 9 trials]i and decreased low birthweight [RR 0·73, 95% CI 0·61–0·87; 8 trials] among first and second births.j |
Sources:aImdad et al. (2010); b,cLassi et al. (2013); dImdad and Bhutta (2011); eYakoob et al. (2011); fBhutta et al. (2013); gLu et al. (2014); hImdad and Bhutta (2012); iGarner and Gülmezoglu (2006); jRadeva-Petrova et al. (2014).
Figure 2.Path model of the impact of impact of the key interventions to prevent stunting on stunting prevalence. Notes: Sources of effect sizes: (A) Balanced energy supplementation–Imdad and Bhutta (2011) (B) IPTp–Eisele et al. (2010) (C) Multiple micronutrient supplementation–Haider et al. (2011); Pena-Rosas et al. (2015); Haider and Bhutta (2015) (D) Breastfeeding practices–Victora et al. (2016); Singha et al. (2015) (E) Vitamin A supplementation–Imdad et al. (2011) (F) Past stunting–LiST default values based on expert opinion (G) Birth outcomes–LiST default values based on expert opinion. (H) Complementary feeding–Imdad et al. (2011) (I) Diarrhoea incidence–Bhutta et al. (2008) (J) Zinc supplementation–Yakoob et al. (2011); Bhutta et al. (2013)
Minimum, maximum and population-weighted average unit cost used to estimate the cost of scale-up in a sample of 37 high burden countries (USD)
| Intervention | Minimum (USD) | Maximum (USD) | Population-weighted average unit cost (USD) |
|---|---|---|---|
| Vitamin A supplementation | $0.03 | $4.81 | $0.32 |
| Breastfeeding and complementary feeding counselling | $0.07 | $12.00 | $6.62 |
| Public provision of complementary foods | $29.03 | $115.28 | $42.93 |
| Prophylactic zinc | $2.40 | $6.19 | $3.89 |
| Multiple micronutrient supplementation for pregnant women | $1.80 | $7.55 | $2.80 |
| Balanced energy-protein supplementation for pregnant women | $16.93 | $54.72 | $24.07 |
| Intermittent preventive treatment in pregnancy | $2.27 | $2.27 | $2.27 |
Figure 3.Projected reductions in the numbers of stunted children resulting from KIPS and from improvements in the underlying determinants of malnutrition 2016–25 (millions)
Global financing needs estimates for the 10-year scale-up of kips in low and middle income countries worldwide (USD million)
| Intervention | Total 10-year Intervention costs | Share of total 10-year cost |
|---|---|---|
| Vitamin A supplementation | 716 | 2% |
| Breastfeeding promotion, complementary feeding education and promotion of good infant and young child nutrition practices: | 6823 | 15% |
| Public provision of complementary foods | 12 750 | 29% |
| Prophylactic zinc supplementation | 14 212 | 32% |
| Multiple micronutrient supplementation for pregnant women | 2309 | 5% |
| Balanced energy-protein supplementation | 6949 | 16% |
| Intermittent preventive treatment for malaria in pregnancy | 416 | 1% |
| Subtotal | 44 175 | 100% |
| M & E | 883 | |
| Policy development | 442 | |
| Capacity strengthening | 3976 | |
| 10 year total | 49 476 |
Figure 4.Future financing projections for nutrition under assumptions of business as usual (USD millions)
Figure 5.Future financing projections for nutrition under assumptions of global solidarity (USD million)